Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
5
×
indiana top stories
life sciences
national
national blog main
5
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
5
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
biotech
texas blog main
fda
department of health and human services
drug prices
medicare
regeneron pharmaceuticals
scott gottlieb
alex azar
alirocumab
alnylam pharmaceuticals
ambys medicines
american patients first
amicus therapeutics
ampio pharmaceuticals
What
long
5
×
awaited
drug
drugs
house
plan
prices
details
lower
trump
unveiled
white
adapt
administration
afternoon
anathema
anticipated
aren’t
bio
blueprint
canada
canadian
cells
cellular
changes
cheaper
cost
costly
countries
cut
democrat
department
developers
elements
excludes
fda
floats
gene
goes
health
Language
unset
unknown
Current search:
" raleigh-durham blog main "
×
" indiana blog main "
×
" national blog main "
×
long
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
6 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details